Kling Biotherapeutics B.V.
1 clinical trials · Sponsor
◉ Watch Kling Biotherapeutics B.V.
| Record | Firm | Date |
|---|---|---|
| Study of KBA1412 in Participants With Advanced Solid Malignant Tumors (NCT05501821) | Kling Biotherapeutics B.V. | 2022-08-08 |
Track Kling Biotherapeutics B.V. automatically
Every clearance here is in the API, with alerts when new ones post.